Skip to main content

Aquestive Therapeutics, Inc 8-K, filed Oct 19, 2026

Aquestive Therapeutics, Inc. (AQST)

8-K 2026-10-19 For: 2026-10-15
View Original
Added on October 20, 2026

About this 8-K

Aquestive Therapeutics, Inc filed this 8-K on October 19, 2026, reporting on events of October 15, 2026.

On October 15, 2026, Aquestive Therapeutics, Inc.’s Board adopted amended and restated bylaws, eliminating a disclosure requirement concerning certain relationships and revising the definition of “Stockholder Associated Person” to exclude persons “acting in concert.” AI summary

Items reported

  • Item 5.03: Charter or bylaw amendment, or fiscal year change
  • Item 9.01: Financial statements and exhibits